{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T20:14:26Z","timestamp":1769717666812,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,12,21]],"date-time":"2013-12-21T00:00:00Z","timestamp":1387584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s10067-013-2454-5","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T05:25:38Z","timestamp":1387517138000},"page":"429-433","source":"Crossref","is-referenced-by-count":5,"title":["Recurrent episodes of hemorrhagic alveolitis in relapsing catastrophic antiphospholipid syndrome: the same side of the dark moon"],"prefix":"10.1007","volume":"33","author":[{"given":"Filippo","family":"Pieralli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Grazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vieri","family":"Vannucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Cammelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Nozzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,21]]},"reference":[{"key":"2454_CR1","first-page":"508","volume":"19","author":"RA Asherson","year":"1992","unstructured":"Asherson RA (1992) The catastrophic antiphospholipid syndrome. J Rheumatol 19:508\u2013512","journal-title":"J Rheumatol"},{"key":"2454_CR2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","volume":"12","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC et al (2003) Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12:530\u2013534","journal-title":"Lupus"},{"key":"2454_CR3","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.1780400823","volume":"40","author":"MC Neuwelt","year":"1997","unstructured":"Neuwelt MC, Daikh DL, Linfoot JA, Pfister DA, Young RG, Webb RL et al (1997) Catastrophic antiphospholipid syndrome. Response to repeated plasmapheresis over three years. Arthritis Rheum 40:1534\u20131539","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2454_CR4","first-page":"556","volume":"100","author":"A Undas","year":"1998","unstructured":"Undas A, Swad\u017aba J, Undas R, Musial J (1998) Three episodes of acute multiorgan failure in a woman with secondary antiphospholipid syndrome. Pol Arch Med Wewn 100(6):556\u2013560","journal-title":"Pol Arch Med Wewn"},{"issue":"6","key":"2454_CR5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/096120339900800613","volume":"8","author":"KC Cerveny","year":"1999","unstructured":"Cerveny KC, Sawitzke AD (1999) Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura? Lupus 8(6):477\u2013481","journal-title":"Lupus"},{"key":"2454_CR6","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/art.22018","volume":"54","author":"S Bucciarelli","year":"2006","unstructured":"Bucciarelli S, Espinosa G, Cervera R, Erkan D, G\u00f3mez-Puerta JA, Ramos-Casals M (2006) Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 54:2568\u20132576","journal-title":"Arthritis Rheum"},{"key":"2454_CR7","first-page":"628","volume":"9","author":"M Garc\u00eda-Carrasco","year":"2007","unstructured":"Garc\u00eda-Carrasco M, Esc\u00e1rcega RO, Mendoza-Pinto C, Zamora-Ustaran A, Etchegaray-Morales I, Rojas-Rodriguez J (2007) Preventing death in the catastrophic antiphospholipid (Asherson) syndrome. Isr Med Assoc J 9:628\u2013629","journal-title":"Isr Med Assoc J"},{"issue":"8","key":"2454_CR8","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/ard.2004.025759","volume":"64","author":"R Cervera","year":"2005","unstructured":"Cervera R, Font J, Gomez-Puerta J, Espinosa G, Cucho M, Bucciarelli S, Ramos-Casals M, Ingelmo M, Piette J, Shoenfeld Y, Asherson R (2005) Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 64(8):1205\u20131209, Epub 2005 Feb 11","journal-title":"Ann Rheum Dis"},{"key":"2454_CR9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/0961203312436866","volume":"21","author":"R Cervera","year":"2012","unstructured":"Cervera R (2012) CAPS registry. Lupus 21:755\u2013757","journal-title":"Lupus"},{"key":"2454_CR10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/0961203309106833","volume":"18","author":"S Bucciarelli","year":"2009","unstructured":"Bucciarelli S, Espinosa G, Cervera R (2009) The CAPS registry: morbidity and mortality of the catastrophic antiphospholipid syndrome. Lupus 18:905\u2013912","journal-title":"Lupus"},{"issue":"6","key":"2454_CR11","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semarthrit.2007.08.001","volume":"37","author":"RA Asherson","year":"2008","unstructured":"Asherson RA, Espinosa G, Menahem S, Yinh J, Bucciarelli S, Bosch X, Cervera R (2008) Relapsing catastrophic antiphospholipid syndrome: report of three cases. Semin Arthritis Rheum 37(6):366\u2013372","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"2454_CR12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.semarthrit.2012.05.005","volume":"42","author":"G Espinosa","year":"2013","unstructured":"Espinosa G, Rodr\u00edguez-Pint\u00f3 I, Gomez-Puerta JA, Pons-Estel G, Cervera R (2013) Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies). Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses. Semin Arthritis Rheum 42(4):417\u2013423","journal-title":"Semin Arthritis Rheum"},{"key":"2454_CR13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/BOR.0b013e32835b4449","volume":"25","author":"J Graf","year":"2013","unstructured":"Graf J (2013) Rheumatic manifestations of cocaine use. Curr Opin Rheumatol 25:50\u201355","journal-title":"Curr Opin Rheumatol"},{"key":"2454_CR14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MAJ.0b013e31822979f1","volume":"342","author":"S John","year":"2011","unstructured":"John S, Manda S, Hamrock D (2011) Cocaine-induced thrombotic vasculopathy. Am J Med Sci 342:524\u2013526","journal-title":"Am J Med Sci"},{"key":"2454_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11239-012-0711-0","volume":"34","author":"S Gulati","year":"2012","unstructured":"Gulati S, Donato AA (2012) Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature. J Thromb Thrombolysis 34:7\u201310","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"2454_CR16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.imbio.2005.10.002","volume":"210","author":"RA Asherson","year":"2005","unstructured":"Asherson RA (2005) Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome. Immunobiology 210(10):727\u2013733","journal-title":"Immunobiology"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2454-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2454-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2454-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:30Z","timestamp":1559120250000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2454-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,21]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["2454"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2454-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,21]]}}}